AmCad BioMed Corporation (TPEX:4188)
Taiwan · Delayed Price · Currency is TWD 11.85
+0.05 (0.42%)
May 8, 2026, 1:30 PM CST
AmCad BioMed Market Cap
AmCad BioMed has a market cap or net worth of 750.49 million as of May 8, 2026. Its market cap has decreased by -11.24% in one year.
Market Cap
750.49M
Enterprise Value
469.42M
Revenue
30.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.85
Market Cap Chart
Since December 26, 2013, AmCad BioMed's market cap has decreased from 905.63M to 750.49M, a decrease of -17.13%. That is a compound annual growth rate of -1.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 750.49M | -19.39% |
| Dec 31, 2025 | 930.99M | -34.23% |
| Dec 31, 2024 | 1.42B | -0.45% |
| Dec 29, 2023 | 1.42B | 67.51% |
| Dec 30, 2022 | 848.88M | -17.57% |
| Dec 30, 2021 | 1.03B | 0.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NaviFUS | 1.27B |
| Rossmax International | 1.21B |
| Diamond Biotechnology | 1.21B |
| AViTA | 1.16B |
| Wiltrom | 1.08B |
| PlexBio | 1.07B |
| S&S Healthcare Holding | 916.10M |
| Radiant Innovation | 802.38M |